Intriguingly, we observed a statistically significant inverse correlation between MDM2 and HBP1 protein levels in human uterine cervix cancer, thyroid cancer, and breast cancer with high expression of MDM2 (compared with carcinoma versus para-carcinoma) using immunohistochemistry assay (Fig. 1a). The gene discussed is MDM2; the disease is thyroid gland carcinoma.